Ventas Inc. Stock
Ventas Inc. Stock
With only a change of €0.020 (0.040%) the Ventas Inc. price is nearly unchanged from yesterday.
The community is currently still undecided about Ventas Inc. with 1 Buy predictions and 0 Sell predictions.
Pros and Cons of Ventas Inc. in the next few years
Pros
?
Conscious of the environment
?
Worthwhile Investment for the next years
?
Market Position
Cons
?
Growth compared to competition
?
Shareholder structure
?
Brand
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ventas Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ventas Inc. | 0.040% | 2.533% | 7.956% | 37.601% | 21.420% | 2.989% | 26.837% |
| Weyerhaeuser Co. | -0.140% | -0.522% | -8.685% | 43.589% | 5.263% | -10.119% | 12.585% |
| Welltower Inc | 2.140% | 4.090% | 12.571% | 35.821% | 31.329% | 35.835% | 56.474% |
| Healthpeak Properties Inc. | 0.460% | 0.985% | 4.706% | 15.354% | 18.156% | 38.313% | 17.884% |
Other discussions about Ventas Inc. Stock
New thread ForumNews
Ventas to Present at Nareit’s REITweek 2021 Investor Conference
Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will make a presentation regarding the Company at Nareit’s REITweek 2021 Investor Conference (the “Nareit
Ventas Declares Second Quarter 2021 Dividend of $0.45 per Common Share
Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on
Ventas to Present at RBC Capital Markets Global Healthcare Conference
Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will make a presentation regarding the Company at the virtual RBC Capital Markets Global Healthcare Conference
